Skip to main content

El-Hibri Fuad

Director | Chairman | Executive Chairman +1 more

2 companies

El-Hibri Fuad is a Director at Emergent BioSolutions Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 9 sells.

Estimated insider holdings value: $25.4M based on current market prices.

Holdings by Company

EBSDec 3, 2021
Current Shares3.02M
Value$25.42M
Net Activity-1,485,421
Bought: 0Sold: 1.49M
APVODec 3, 2021
Current Shares7.4K
Value$32.3K
Net Activity+300.0K
Bought: 300.0KSold: 0

Transaction History

Showing 10 filings (page 3)
DateTickerRoleTypeSharesPriceValueChg%SEC
Jul 19, 2019
APVO
Aptevo Therapeutics Inc.
Board Of DirectorsBuy26,460$0.90$23,739.91+2.9%
Jul 18, 2019
APVO
Aptevo Therapeutics Inc.
Board Of DirectorsBuy14,404$0.87$12,596.30+1.6%
Jul 17, 2019
APVO
Aptevo Therapeutics Inc.
Board Of DirectorsBuy19,136$0.87$16,703.81+2.2%
Jul 16, 2019
APVO
Aptevo Therapeutics Inc.
Board Of DirectorsBuy11,375$0.85$9,661.93+1.3%
Jul 11, 2019
APVO
Aptevo Therapeutics Inc.
Board Of DirectorsBuy14,691$0.85$12,453.56+1.7%
Jul 10, 2019
APVO
Aptevo Therapeutics Inc.
DirectorBuy18,919$0.85$16,058.45+2.3%
Feb 28, 2019
EBS
Emergent Biosolutions Inc.
ChairmanSale+OE27,725$58.83$1,630,931.30-0.6%
Nov 27, 2018
EBS
Emergent Biosolutions Inc.
ChairmanSell45,832$69.79$3,198,698.88-1.6%
Nov 20, 2018
EBS
Emergent Biosolutions Inc.
ChairmanSell35,173$69.75$2,453,365.19-1.2%
Aug 14, 2018
EBS
Emergent Biosolutions Inc.
ChairmanSell36,318$55.98$2,033,109.26-1.2%